Shenzhen Hepalink Reports 1.3% Decline in Revenue and 36.4% Drop in Profit for H1 2025

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. announced its unaudited consolidated interim results for the six months ended June 30, 2025. The Group reported a total revenue of approximately RMB2.791 billion, a slight decrease of 1.3% from RMB2.829 billion in the same period of 2024. The gross profit for the period was approximately RMB809.2 million, down 19% from RMB999.3 million in the previous year, with a gross profit margin of 29.0%, compared to 35.3% in 2024. Net profit attributable to equity holders was approximately RMB421.9 million, reflecting a significant decline of 36.4% from RMB663.7 million in the corresponding period of the prior year. This decrease in net profit was primarily attributed to the absence of a significant one-off investment gain that positively impacted the results in the previous year. During the reporting period, sales of formulation products achieved significant growth, with volume increasing by over 30% and sales revenue reaching approximately RMB1.768 billion, a 21.6% year-on-year increase from RMB1.454 billion, accounting for about 63.3% of the Group's total revenue. Despite this growth, the gross profit margin for these products decreased to 27.8% from 34.0% in the previous year, influenced by strategic price adjustments in certain regional markets and changes in U.S. market tariff policies. The Group focused on strengthening its market competitiveness and promoting business expansion through structural adjustments to sales prices in specific regions, aiming to support sustainable development through efficient capital allocation and risk management.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Hepalink Pharmaceutical Group Co. Ltd. published the original content used to generate this news brief on August 29, 2025, and is solely responsible for the information contained therein.